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Informed Consent
for Medical Research:
Case Studies
Catherine A. Marco, M.D., FACEP

ABSTRACT

Informed consent for medical research is an essential, but challenging, process to assure the protection of the rights of
potential research subjects. Numerous barriers to the informed consent process exist among patients, including impaired
decisional capacity, impaired cognition, language barriers, illiteracy, insufficient time and communication, and numerous
others. Because of the inherent vulnerability of patients, particular attention should be paid to addressing barriers to
adequate informed consent, and steps should be taken to ensure adequate delivery of information, understanding of the
study and its risks and benefits, and voluntariness of the informed consent.

CASE ONE

INTRODUCTION

A 56-year-old female presents to the emergency
department with chest pain, and is found to have an acute
myocardial infarction. She meets all inclusion criteria for
a research study to evaluate a novel therapeutic modality
for treatment of acute myocardial infarction. The research
assistant approaches the patient, who is suffering from
ongoing pain and anxiety. The research assistant presents a
six-page informed consent document for signature to the
patient, who willingly signs the document in triplicate.

The doctrine of Informed Consent is a fundamental
principle of the U.S. legal system, introduced by case
law in 1957. Informed consent and refusal of treatment
are recognized as important legal and ethical rights of
patients.1 Although physicians, by virtue of education
and training, typically make diagnoses and recommend
treatment, individual patients have the rights and
abilities to decide whether the proposed interventions
are acceptable. Informed consent represents one of the
most fundamental rights of patient autonomy in medical
decision making.2,3,4,5,6,7 As with informed consent for
procedures, informed consent for research is a process,
not merely a document. The process should include the
delivery of information regarding the study, its risks and
benefits, demonstration of adequate understanding of
the potential research subject, voluntary agreement to
participate, and documentation of the agreement.

CASE TWO

A 24-year-old male presents with a laceration to the
forearm. He meets inclusion criteria for a research study to
evaluate the efficacy of a newly developed suture material.
His primary language is Spanish, although he speaks
some limited English. He cannot read in any language.
The research assistant approaches the patient and requests
his signature on an informed consent document to
participate in the research protocol. Due to the brevity
of the discussion, the research assistant was unaware of
the patient’s illiteracy and the patient willingly signed the
document.

ESSENTIAL ELEMENTS OF INFORMED CONSENT FOR
RESEARCH

Informed consent for research should be appropriately
worded, understandable, and should address multiple
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issues of importance to the potential research subject,
including an explanation of the purposes of research,
duration of participation, description of the study, risks,
benefits, alternates, confidentiality, compensation, and
information about voluntariness.8,9,10,11,12,13
The language of informed consent is essential to
ensuring the adequate information delivery to potential
research subjects. Informed consent documents and
discussion should be written and delivered at a reading
level appropriate to the potential subject. This may require
some individual adaptation, particularly of the informed
consent discussion.
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TABLE 1: BARRIERS TO ADEQUATE INFORMED CONSENT
Acute medical or traumatic conditions
Impaired decisional capacity
Impaired cognition
Psychiatric illness
Intoxication with illicit or pharmaceutical agents
Language barriers
Pain
Anxiety
Speech or hearing deficits
Illiteracy
Time constraints
Inadequate communication skills
Lack of understanding of voluntariness

ENSURING SUBJECTS’ UNDERSTANDING

There exist many unanswered questions about the ideal
informed consent process, the ideal ways to appropriately
inform patients of risks and benefits in ways that improve
understanding and retention of information presented.
Several recent reports indicated that a majority of patients
prefer detailed information compared to abbreviated information, when asked directly.14,15,16 Several recent studies
demonstrated that research subjects’ understanding of
detailed informed consent is poor.17,18,19 Another study
demonstrated improved information retention with a
short form, compared to a more detailed form.20 Another
recent study demonstrated that subjects may be less
willing to participate in a hypothetical study when explicit
statistical information is presented, compared to abbreviated information.21 Although many informed consent
documents are written at an inappropriately high reading
level,22,23,24 careful attention to the written informed
consent document and its linguistics can improve its
readability.25
While obvious cognitive impairments are usually
recognized, minimal cognitive impairments may be
overlooked. A detailed discussion with the potential
subject, including feedback from the subject regarding
their understanding of risks and benefits, may elucidate
the level of understanding, and provide opportunity
for additional education. Safeguards for the cognitively
impaired may include involvement of surrogates, subject
assent, and appropriately balancing the risks and benefits
of participation.26,27

may impair decisional capacity, attention span, ability to
focus, and ability to form and articulate rational questions.
Specific examples of barriers in emergency medicine may
include impaired decisional capacity, distractors (such as
pain or anxiety), time constraints, inadequate communication or delivery of information, illiteracy, language
barriers, limited education, and perceived coercion (see
Table 1). Because of these numerous potential barriers
to the informed consent process, it is essential that
emergency medicine researchers address and attempt to
overcome any existing barriers. The rights of individual
patients must always be protected, above that of specific
research interests.
AVOIDING COERCION

Coercion of potential research subjects, either overt
or masked, is unethical. Although most researchers
accept this principle, many continue to coerce subjects in
subtle ways. Examples of inappropriate coercion include
excessive monetary incentives, failure to inform the subject
of voluntariness of participation, repeated questioning,
inappropriate representation of the study benefits,
withholding of care prior to consent, and numerous
others. Any form of coercion must be avoided.
SUPERVISION OF RESEARCH ASSISTANTS

The principle investigator assumes responsibility for
the design of the informed consent document and for the
informed consent process, although these duties may be
delegated to co-investigators or research assistants. The
investigator has a duty to ensure that all research assistants
have been adequately trained in human subjects’ rights, in
privacy and confidentiality, and in the individual research
protocol. Additionally, training and ongoing supervision
of the informed consent process specific to the protocol
are the responsibility of the investigator.

BARRIERS TO THE INFORMED CONSENT PROCESS IN
EMERGENCY MEDICINE

The emergency department environment hosts
numerous barriers that can impair aspects of the informed
consent process. Several studies have demonstrated that
acute conditions can impair the ability to appropriately
give consent.28,29 Emergency department patients are
inherently vulnerably, by virtue of their situation. They
typically seek help for emergent or urgent conditions that
36
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CASE DISCUSSION

Case One

This case depicts some of the inherent difficulties with
emergency medicine research. The patient was in obvious
distress and may not have possessed her usual ability
to focus and discuss complex issues. Much emergency
research endeavors to study patient populations who
may be in distress related to their presenting conditions.
When studying such patient populations, the recognition
of inherent vulnerability must be recognized and specific
steps taken to avoid the inappropriate coercion of such
patients. Specifically, patients should be informed of the
voluntary nature of participation, and should be assured
that prompt and appropriate medical care will be given,
regardless of research participation.
Case Two

This case depicts language and literacy barriers to the
informed consent process. Such barriers may be unrecognized, particularly if the informed consent discussion is
very brief. When enrolling research subjects with potential
language or literacy deficiencies, particular attention
should be paid to ensuring their full understanding of the
study and potential risks and benefits of participation.
For some patients, this may require additional time with
verbal discussions, utilizing the services of an interpreter,
or involving a family member who may assist with
interpreting or understanding. Because of the inherent
vulnerability of such patients, special attention should
be paid to avoiding coercion of any type, and ensuring
understanding of the voluntariness of participation.
CONCLUSIONS

Informed consent for research in emergency medicine
is an essential element of the protection of human subjects’
rights, yet it remains a complex and challenging process.
Investigators must strive to not only meet the letter of the
law found in federal guidelines, but to also address the
individual needs of individual potential research subjects
to protect their rights and welfare.
Catherine A. Marco, M.D., FACEP is an emergency medicine
physician at St. Vincent Mercy Medical Center in Toledo,
Ohio.
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